Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Cash from Investing Activities Growth (1y) (2018 - 2026)

Analysis

Catheter Precision (VTAK) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -15.64%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -110.20%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -125.17%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -514.42%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -73.71%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -12.26%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -44.16%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 618.55%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 0.00%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 -6,307.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6,307.69%
Mar 31, 2026 -13,090.00%
Jun 30, 2025 71.11%
Mar 31, 2025 54.55%
Jun 30, 2024 -125.00%
Mar 31, 2024 0.00%
Dec 31, 2023 -185.71%
Dec 31, 2022 2,200.00%
Dec 31, 2021 -120.00%
Sep 30, 2021 14,643.48%
Jun 30, 2021 -96.61%
Mar 31, 2021 -97.37%
Dec 31, 2020 -99.95%
Sep 30, 2020 -100.22%
Jun 30, 2020 113.64%
Mar 31, 2020 6,749.70%
Dec 31, 2019 6,398.73%
Sep 30, 2019 6,269.36%
Jun 30, 2019 -27,756.49%
Mar 31, 2019 -37.50%